home.social

#abbv — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #abbv, aggregated by home.social.

  1. ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression

    AbbVie ABBV has announced a deal with private neuroscience biotech, Gilgamesh Pharmaceuticals, to acquire the latter’s lead pipeline…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #ABBV #AbbVie #GilgameshPharmaceuticals #Health #MADRS #MentalHealth #ZacksInvestmentResearch
    newsbeep.com/us/115696/

  2. ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression

    AbbVie ABBV has announced a deal with private neuroscience biotech, Gilgamesh Pharmaceuticals, to acquire the latter’s lead pipeline…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #ABBV #AbbVie #GilgameshPharmaceuticals #Health #MADRS #MentalHealth #ZacksInvestmentResearch
    newsbeep.com/us/115696/

  3. ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression

    AbbVie ABBV has announced a deal with private neuroscience biotech, Gilgamesh Pharmaceuticals, to acquire the latter’s lead pipeline…
    #NewsBeep #News #Mentalhealth #ABBV #AbbVie #GilgameshPharmaceuticals #Health #MADRS #MentalHealth #UK #UnitedKingdom #ZacksInvestmentResearch
    newsbeep.com/uk/96577/

  4. AbbVie (ABBV)

    #Tradingan - #Grafik #harga #saham #AbbVie (ABBV) hari ini untuk membantu #analisa #pasar sebelum memulai #investasi dan #trading saham AbbVie #ABBV. AbbVie Inc. (NYSE: ABBV) adalah #perusahaan #biofarmasi global yang berfokus pada #pengembangan dan #komersialisasi obat-obatan #inovatif, terutama di bidang #imunologi, onkologi, neurosains, dan virologi. Perusahaan ini terkenal berkat obat Humira, salah satu obat terlaris di dunia untuk penyakit autoimun…

    tradingan.com/abbvie

  5. AbbVie (#ABBV) reported an actual EPS of $2.31, slightly higher than the forecasted $2.27. Additionally, its revenue beat expectations, with actual revenue at $12.31 billion compared to the forecasted $11.93 billion. #AbbVie #earnings

  6. AbbVie (#ABBV) reported an actual EPS of $2.31, slightly higher than the forecasted $2.27. Additionally, its revenue beat expectations, with actual revenue at $12.31 billion compared to the forecasted $11.93 billion. #AbbVie #earnings